CureSight Ixpoliyotl Patlalistli Tlachihualli ītēchcopa Kobi Kor

Tlanāhuatīlli CureSight Ixpoliyotl Patlalistli Tlachihualli ītēchcopa Kobi Kor cē cencā mahuizzō tēmacēhualōni īpan huēyi 2022 Mahuizolli A' Design Award Tepoztli īpan Pahtiliztli Tepoztlachihualli ihuan Pahtiliztli Tequitilli Tlachihchihualiztli Nēhuilīztli Tlamantli.

TepoztliPahtiliztli Tlachihualli· 2022

CureSight Ixpoliyotl Patlalistli Tlachihualli

īpal Kobi Kor

Tlanāhuatīlli: Novasight

Mahuizolli A' Design Award Tepoztli Tēmacēhualōni īpan Pahtiliztli Tlachihualli Tlamantli

22,237

Tlaneltīlīlli Tēmacēhualōni

Xictlaneltilia Tēmacēhualli ītēchcopa #133911

Xicnēxtia axcān Xiquitta Tlahcuilōlcalli Xiquitta A' Design Award ītechcopa Āmatl Tēmachiyōtīliztli Tlamachiōtl

Tlapalli

Tlanēxtilistli

Ītechcopa CureSight Ixpoliyotl Patlalistli Tlachihualli

CureSight itlachihualizyotl oquitlalih ipan ce tlachihualli huan patlaliztli tlen quichihuaz cualli altepeyotl ihuan quitlapalehuiz coconej, amo quinequizqueh netlaliloliztli ihuan pinahuiliztli ipan yancuic patlaliztli ica ixehuatl. Tlachihualli no quitenehualiz ca inezi ihuan imatiz monequi inic chicahuazqueh coconej. Tlachihualizyotl omotlalih ipan tlamachiyomeh tlen coconej quinequih quimatih ihuan mahuiltihtoqueh. Tonalnemiliztli quitta ce yancuic ihuan cualli neci patlalitlachihualli.

Tēixīmachōtiliztli

Ītechcopa Mahuizolli A' Design Award Tepoztli

CureSight Ixpoliyotl Patlalistli Tlachihualli ca in quicuic in Mahuizolli A' Design Award Tepoztli, tlamahuizoliztli tlen momaca in cualli dizayno in quitlalia in tlen monequi ipan tequitl ihuan tlachihualiztli in quimaca in cualli tlachihualli. In quicuicah Tepoztli quinextia in hueyi tlamatiliztli, toltecayotl ihuan ihuelitiliztli intlachihuanime. Ca quinequi in CureSight Ixpoliyotl Patlalistli Tlachihualli ca tlazohtli, mahuiztic, yancuic ihuan motequiuhtia. Ni dizayno in quicuic Tepoztli quihuelitia in tlamatiliztli ihuan quipia chicahualiztli tlen tepoztli. CureSight Ixpoliyotl Patlalistli Tlachihualli quicualtia in nemiliztli ihuan quihuelitia in cemanahuac ica cualli.

Tlanēxtilistli Ītēixpan

Āmatl Tlanextīliztli

Tlapōhualli, tēquitqueh īwan tēchmachilīztli ōquinmaca in tlanēxtīlīlli.

Cē Zan Ītēchcopa: The curesight is a powerful solution with great potential to totally change the treatment of lazy eye condition, with the important advantage of treating the lazy eye from the comfort of home and by watching any tv or streaming video content.
This healthcare solution for lazy eye condition integrates high-end technologies for eye-tracking and ai software tools for smart analyzing of the lazy eye condition and providing personal custom treatment. The gold standard care for lazy eye is placing a patch over the strong eye, an old-fashioned solution that suffers from very low compliance.
Huēyiliztli īhuān Tlacualtepēhualli: product net dimensions
Height 230mm
Width 390mm
Depth 60mm
Tōcāitl: amlyopia, lazy eye, medical device, product design, social impact, degital healthcare
Tlachīhualiztli Māchiyōtl: The design activity started with a brainstorming meeting to learn more about the problem from the clinical and user needs aspects, and to outline the main big limitations of today's treatment methods.
We also discussed the ergonomics and usability needs to be able to provide the best treatment.
during the design process, we tested several design concepts both aesthetically and with physical mockups,
Production technologies include aluminum CNC machining and anodize plating, for the front bezel and plastic injection for the back cover and small covers.
Tlanāhuatīlli Nētēcahuilīztli: The creative challenge was to dress the unique technology components with style and to provide a good user experience to the users, the specific usability needs to enable good treatment for various populations and make it an appealing and empowering treatment device, and lead to important social impact
Tlatēmōliztli: Following an intense effort over the last 18 months, the company officially announced that the company successfully met the primary endpoint of the CureSight randomized, controlled pivotal trial of amblyopia treatment against the gold standard patching.
This is the first-ever pivotal study in which a digital device was shown to be non-inferior to eye patching for amblyopia treatment in children.
The study also exhibited 93% adherence to the curesight treatment, as well as a 93% likelihood of the parents choosing curesight over patching.
Tēyōllālīliztli: The inspiration for the curesight product started from a personal experience when one of my kids needed to treat the lazy eye condition with the eye patch solution, I learned from this experience about the discomfort of wearing the eye patch for a few hours every day and especially how embarrassing it is from the social point of view.
The inspiration for the styling design came from the tech gadgets that kids love to use and play with, to provide a slick and modern design to a medical device product type, the front aluminum bezel, and the back swallowtail gives the product a clean gadget look.
Tēquitl Cāhuitl: The project started in 2019 in Tel Aviv, and finished in late 2021, the project was exhibited at the CES in January 2020 in Las Vegas
Tēquitl Ōhuitl: The patient, most likely kids will have the fun be treated by the Curesight while watching any video content they love to watch without any degradation in quality and from the comfort of home.
Calpolli Tlācah: Kobi Kor
Tal Samet
Īxiptla Tlanēxtīlli: All images
Photograph and Illustrations: Novasight and Kobi Kor